Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo
about
Commonly used methods of complementary medicine in the treatment of breast cancerSoy and Health Update: Evaluation of the Clinical and Epidemiologic LiteratureAnti-inflammatory activity of soy and tea in prostate cancer preventionToxic phytochemicals and their potential risks for human cancerUrinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study.Long-term exposure to dietary sources of genistein induces estrogen-independence in the human breast cancer (MCF-7) xenograft model.Isoflavones - Mechanism of Action and Impact on Breast Cancer RiskSteroidal metabolites transformed by Marchantia polymorpha cultures block breast cancer estrogen biosynthesis.A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patientsPotential utility of natural products as regulators of breast cancer-associated aromatase promotersSoy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer riskDiverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property?Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice.Endocrine resistance in breast cancer--An overview and update.Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.The Public Health Impact of Herbs and Nutritional Supplements.Adding Agnus Castus and Magnolia to Soy Isoflavones Relieves Sleep Disturbances Besides Postmenopausal Vasomotor Symptoms-Long Term Safety and EffectivenessChallenges in clinical patient management.Risks and benefits of dietary isoflavones for cancer.Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice.Can breast cancer patients use soyafoods to help reduce risk of CHD?Drug interactions and the pharmacist: focus on everolimus.Non-clinical toxicity studies on bioactive compounds within the framework of nutritional and health claims.Comparison of the effects of nobiletin and letrozole on the activity and expression of aromatase in the MCF-7 breast cancer cell line.Long-term soy consumption and tumor tissue MicroRNA and gene expression in triple-negative breast cancer.Glycone-rich Soy Isoflavone Extracts Promote Estrogen Receptor Positive Breast Cancer Cell Growth.Vaginal Health During Breast Cancer Treatment.Effects of phytoestrogen extracts isolated from pumpkin seeds on estradiol production and ER/PR expression in breast cancer and trophoblast tumor cells.Soy protein extract (SPE) exhibits differential in vitro cell proliferation effects in oral cancer and normal cell lines.Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study.Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women.Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavonesTrends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014.Lifetime Genistein Intake Increases the Response of Mammary Tumors to Tamoxifen in Rats.Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells.Metabolomics Reveals that Dietary Xenoestrogens Alter Cellular Metabolism Induced by Palbociclib/Letrozole Combination Cancer Therapy.Intake of phytoestrogen foods and supplements among women recently diagnosed with breast cancer in Ontario, Canada.Red clover and soy isoflavones--an in vitro safety assessment.Effect of Soy Isoflavone on Hot Flushes, Endometrial Thickness, and Breast Clinical as well as Sonographic Features.Postdiagnosis Isoflavone and Lignan Intake in Newly Diagnosed Breast Cancer Patients: Cross-Sectional Survey Shows Considerable Intake from Previously Unassessed High-Lignan Foods
P2860
Q27691359-0800CA54-A080-40E8-84A1-2350D6E40C0EQ28071946-0ACDD22F-2D67-4CA8-A082-FF50220B96B3Q28391888-21AF3ADD-3471-43CA-BFFE-46D89351DAB5Q28652418-FA547B4C-0EE5-4942-AC4A-427A68906523Q33742262-CC80D91E-7E1F-4AF5-9E18-7D2051389574Q34084662-0288737D-AB85-47A1-8AD7-4EEBDC0A3269Q34140151-B35A7E43-5165-43F3-BEF4-2A42032F90D9Q34164697-FEA36FFD-A0DF-45CB-BA8D-F8726063A7CEQ35092002-CEA357E3-3C20-4077-ABF5-F51EA2C086EFQ35124690-04CFB0CD-7909-4596-8E35-3024CB81DEEFQ35335557-6D03292F-E085-42A1-A5B2-DA9D4AED9F26Q35653376-EF9DBB98-6DE5-4CF8-8A0C-945E245B232BQ35883554-10278689-A0E5-46A6-9A0F-6D8A62B69145Q36386322-E7334870-ACEE-4199-99B7-3682338BE517Q36941450-6E0444C1-F8BB-48A0-971C-149ECF1B9640Q37408863-CC4DF6E1-EB46-46BD-9840-D81B1C8A0E87Q37673193-7D17823B-3BA7-47AE-A8E1-D78C48D60FE7Q37775020-2B7A225B-EAD6-4362-9A43-EFFD8347C5E8Q37857841-BA3F8FED-F4B7-404A-8A6E-ED713A958A33Q37965541-ED587868-891A-476D-84DA-632AC3293443Q38032972-69800E0F-BCA8-40A9-9EB8-295631940EEDQ38113771-3930ABC6-7F27-405D-A66F-D721CE61A5DFQ38560455-DAFADCC4-88FC-4EA6-817E-B2C22C614AFAQ38717355-E124ED17-2256-40DE-8A05-C4CA4084DFA0Q38770659-BDC75127-5777-40EC-B456-01ACCB399C93Q38780897-D6A7AFA6-8705-4D64-938F-E868BBFF19CFQ38807445-DC1D3A73-A421-47DA-9CCA-8E3A3E823F09Q39125239-33AE0798-7A5D-47A9-B9A8-E55CAD504165Q39376475-988D0440-2675-402D-9A41-9C9FF2B9F828Q43743259-EDDF914D-B934-40E0-844C-B6D721F6A179Q43959355-62822320-3DC3-4BC5-9CC8-97F850C3A187Q47157326-3550CEAE-E23B-488A-9169-266B19A0DC24Q47358362-A4A6E6F3-A11C-495E-AF0C-22B8C6137397Q47873418-1ED61A48-B54C-4F0C-B5A9-723C2FA606EDQ48226422-90E2F918-FF07-47E8-AF4C-51D55427F5B1Q50033378-68D60EBE-7EE0-4630-BC21-FA68A4DA8A6AQ50510105-0CD8AAEB-9B8F-400E-8FB8-0FFB55945A50Q50528576-E51F8C42-6427-470D-85E6-7F2806C9A51CQ55361625-8BD7CDA6-13A4-4D1E-AAD0-B4131537FCDCQ58133554-75884269-CD23-425F-888C-993BDD2288A7
P2860
Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Dietary genistein negates the ...... cancer cells (MCF-7Ca) in vivo
@ast
Dietary genistein negates the ...... cancer cells (MCF-7Ca) in vivo
@en
type
label
Dietary genistein negates the ...... cancer cells (MCF-7Ca) in vivo
@ast
Dietary genistein negates the ...... cancer cells (MCF-7Ca) in vivo
@en
prefLabel
Dietary genistein negates the ...... cancer cells (MCF-7Ca) in vivo
@ast
Dietary genistein negates the ...... cancer cells (MCF-7Ca) in vivo
@en
P2093
P2860
P356
P1433
P1476
Dietary genistein negates the ...... cancer cells (MCF-7Ca) in vivo
@en
P2093
Daniel R Doerge
James A Hartman
Jieun Kwak
Kellie A Woodling
William G Helferich
Young H Ju
P2860
P304
P356
10.1093/CARCIN/BGN161
P407
P577
2008-07-16T00:00:00Z